as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹25.16
Change
-0.27 (-1.06%)
Open
₹25.01
Prev. Close
₹25.43
Day High
₹25.7
Day Low
₹24.55
Volume Analysis
Traded
160,754
Delivered
784,736
Delivery %
57.89%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •High debt-to-equity ratio (1.58)
- •Below-average fundamentals quality score (37/100)
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹26.88 | ₹26.29 | ₹25.73 | ₹25.14 | ₹24.58 | ₹23.99 | ₹23.43 |
| Fibonacci | ₹26.29 | ₹25.85 | ₹25.58 | ₹25.14 | ₹24.7 | ₹24.43 | ₹23.99 |
| Camarilla | ₹25.48 | ₹25.37 | ₹25.27 | ₹25.14 | ₹25.05 | ₹24.95 | ₹24.84 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+4.57%
1 Week
-6.12%
1 Month
-2.59%
3 Months
-5.38%
6 Months
+12.27%
1 Year
+3.07%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹26.47
Current price is at or below the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
11.28%
Net margin 4.18% × asset turnover 0.78x × equity multiplier 3.46x
Company Overview
Sector
Fast Moving Consumer Goods
Market Cap
₹759 Cr
P/E (TTM)
9.58
ROE
11.1%
Book Value
₹17.9
Face Value
₹1.0
Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.
TopFund Analysis
Mukka Proteins Limited scores weakly on TopFund's composite fundamentals check within the Fast Moving Consumer Goods sector, at 37/100. The strongest factor is Valuation (63/100), while Cash Flow (0/100) is the weakest area to weigh before deciding. Notably: High debt-to-equity ratio (1.58); below-average fundamentals quality score (37/100). FII holding has been falling.
TopFund Score — Fundamentals Quality
37/100 — WeakData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company is expected to give good quarter
- +Company's working capital requirements have reduced from 63.0 days to 45.2 days
- −Though the company is reporting repeated profits, it is not paying out dividend
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Intimation of Investor Presentation - Q2 & FY-27.
Q2 FY27 revenue rose 108% to ₹5,088.70 Mn; PAT up 158%; Oman facility began production.
Mukka Proteins to invest up to Rs 2.13 crore in SESPL for 46% stake by 31-03-2027.
Mukka Proteins approved Q2 FY27 results and ₹2.13 crore investment for 46% stake in SESPL.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 332 | 517 | 257 | 172 | 149 | 303 | 382 | 171 | 245 | 654 | 381 | 490 | 509 |
| Expenses + | 294 | 498 | 224 | 159 | 140 | 262 | 352 | 157 | 224 | 608 | 347 | 443 | 468 |
| Operating Profit | 38 | 19 | 32 | 14 | 10 | 41 | 29 | 14 | 20 | 45 | 34 | 47 | 41 |
| OPM % | 11.0% | 3.6% | 13.0% | 8.0% | 6.0% | 14.0% | 8.0% | 8.0% | 8.0% | 7.0% | 9.0% | 10.0% | 8.0% |
| Other Income + | 6 | 8 | 5 | 3 | 4 | 6 | 4 | 3 | 6 | 8 | 15 | 2 | 9 |
| Interest | 6 | 6 | 7 | 8 | 9 | 11 | 10 | 11 | 13 | 15 | 15 | 16 | 17 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 5 | 6 |
| Profit before tax | 35 | 17 | 27 | 6 | 1 | 33 | 20 | 2 | 9 | 35 | 29 | 27 | 27 |
| Tax % | 18.0% | 31.0% | -8.0% | 5.0% | -40.0% | 19.0% | 30.0% | 33.0% | 26.0% | 21.0% | 26.0% | 32.0% | 35.0% |
| Net Profit + | 29 | 12 | 29 | 5 | 1 | 27 | 14 | 2 | 7 | 27 | 21 | 19 | 18 |
| EPS in Rs | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | — | 30 | -39 | -37 | -55 | -41 | 49 | -1 | 64 | 116 | 0 | 187 | 108 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 409 | 549 | 604 | 770 | 1,177 | 1,380 | 1,006 | 1,449 | 2,033 |
| Expenses + | 385 | 525 | 582 | 723 | 1,091 | 1,274 | 912 | 1,335 | 1,865 |
| Operating Profit | 23 | 24 | 22 | 48 | 86 | 105 | 95 | 115 | 167 |
| OPM % | 6.0% | 4.3% | 3.6% | 6.0% | 7.0% | 8.0% | 9.0% | 8.0% | 8.0% |
| Other Income + | 2 | 8 | 10 | 7 | 8 | 19 | 16 | 31 | 34 |
| Interest | 4 | 7 | 8 | 10 | 16 | 25 | 37 | 54 | 63 |
| Depreciation | 2 | 5 | 8 | 9 | 12 | 12 | 14 | 17 | 20 |
| Profit before tax | 19 | 20 | 15 | 36 | 66 | 87 | 60 | 75 | 118 |
| Tax % | 27.0% | 31.0% | 29.0% | 28.0% | 28.0% | 15.0% | 20.0% | 24.0% | — |
| Net Profit + | 14 | 14 | 11 | 26 | 48 | 74 | 48 | 57 | 85 |
| EPS in Rs | — | — | — | 1 | 2 | 2 | 2 | 2 | 3 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Sales growth | — | 34 | 10 | 28 | 53 | 17 | -27 | 44 | 85 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Reserves | 38 | 51 | 61 | 76 | 126 | 366 | 411 | 469 | 508 |
| Borrowings + | 83 | 142 | 159 | 175 | 262 | 365 | 453 | 779 | 850 |
| Other Liabilities + | 74 | 95 | 129 | 119 | 166 | 179 | 183 | 343 | 472 |
| Total Liabilities | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 | 1,860 |
| Fixed Assets + | 49 | 78 | 79 | 83 | 85 | 85 | 94 | 194 | 223 |
| CWIP | 0 | 2 | 4 | 0 | 0 | 0 | 9 | 31 | 23 |
| Investments | 8 | 4 | 12 | 21 | 21 | 31 | 37 | 56 | 55 |
| Other Assets + | 144 | 209 | 260 | 289 | 469 | 825 | 937 | 1,341 | 1,559 |
| Total Assets | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 | 1,860 |
| Equity Capital | 6 | 6 | 6 | 22 | 22 | 30 | 30 | 30 | 30 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -20 | -25 | 2 | 5 | -56 | -150 | -112 | -111 |
| Cash from Investing Activity + | -23 | -28 | -14 | -11 | -3 | -48 | -35 | -146 |
| Cash from Financing Activity + | 34 | 54 | 13 | 15 | 75 | 266 | 56 | 267 |
| Net Cash Flow | -9 | 1 | 2 | 8 | 15 | 68 | -91 | 10 |
| Free Cash Flow | -39 | -61 | -8 | -1 | -64 | -165 | -130 | -230 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -67 | -81 | 29 | 22 | -52 | -118 | -114 | -84 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 18.21% | 19.09% | 21.84% | 22.06% | 22.05% | 22.71% | 23.31% | 24.8% | 24.97% | 24.93% | 24.77% |
| Promoters | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% |
| FII | 6.46% | 5.08% | 2.81% | 2.63% | 2.63% | 2.08% | 1.7% | 1.7% | 1.7% | 1.73% | 1.7% |
| DII | 2.0% | 2.5% | 2.0% | 1.98% | 1.98% | 1.87% | 1.66% | 0.17% | 0.0% | 0.0% | 0.2% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Fast Moving Consumer Goods — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Mukka Proteins Limited (this stock) | 759 | 9.58 | 1.41 | 11.1% |
| Zuari Industries Limited | 751 | 5.82 | 0.18 | 2.71% |
| Hexagon Nutrition Limited | 780 | 20.4 | 3.19 | 17.1% |
| Elitecon International L | 798 | 4.92 | 2.29 | 63.6% |
| Kokuyo Camlin Limited | 713 | 47.0 | 2.88 | 6.22% |
| Vadilal Enterprises Ltd. | 811 | 4266.0 | 201.72 | 4.79% |
| Dwarikesh Sugar Ind Ltd | 814 | — | — | — |
Which Mutual Funds Hold Mukka Proteins Limited?
Frequently Asked Questions about Mukka Proteins Limited
Mukka Proteins Limited (MUKKA) closed at ₹25.16 on NSE on 19 November 2026, down 0.27 (1.06%) from the previous close.
Mukka Proteins Limited trades on the NSE (National Stock Exchange of India) under the symbol MUKKA.
Mukka Proteins Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 9.58.
Mukka Proteins Limited has a dividend yield of 0.0%.
Mukka Proteins Limited's 52-week high is ₹33.3 and its 52-week low is ₹18.3.
Mukka Proteins Limited has a market capitalisation of ₹759 crore.
Mukka Proteins Limited has a TopFund Quality Score of 37/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Mukka Proteins Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.